Agha Bishr, Shajari Mehdi, Slavik-Lencova Anna, Kohnen Thomas, Schmack Ingo
Department of Ophthalmology, Goethe-University, Frankfurt am Main, Germany,
Clin Ophthalmol. 2019 Mar 7;13:477-482. doi: 10.2147/OPTH.S192424. eCollection 2019.
To evaluate if repeat Descemet membrane endothelial keratoplasty (DMEK) is appropriate to achieve functional improvements in patients with corneal decompensation from secondary graft failure after primary DMEK.
This is a retrospective monocentric cohort study including 13 eyes of 13 patients with repeat DMEK for corneal decompensation following primary DMEK. Eyes with primary DMEK only and comparable preoperative corrected distance visual acuity (CDVA) served as control. Main outcome parameter was CDVA. Secondary outcome measures were central corneal thickness (CCT), endothelial cell density, and rebubbling rate (RR).
The average time interval (±SD) between primary and secondary DMEK was 12.5±6 months. Preoperative CDVA (logMAR) was 1.97±0.90 in the repeat DMEK group and 1.38±0.92 in the primary DMEK group. At 6 months, both groups showed significant improvement in visual acuity (repeat DMEK group, 0.49±0.35, <0.01 and primary DMEK group, 0.40±0.36, <0.01). CDVA did not differ significantly between both groups at all time points examined (1, 3, and 6 months postoperatively). Mean CCT values at 3 and 6 months postoperatively did not differ significantly between the two groups (>0.05). The RR was 23% (n=3) in both groups.
Repeat DMEK is a useful therapeutic approach in the setting of corneal decompensation following primary DMEK. Functional results of repeat DMEK, visual acuity in particular, are comparable to patients with single DMEK only.
评估重复进行Descemet膜内皮角膜移植术(DMEK)是否适合改善初次DMEK术后继发移植失败导致角膜失代偿患者的功能。
这是一项回顾性单中心队列研究,纳入13例因初次DMEK术后角膜失代偿而接受重复DMEK的患者的13只眼。仅接受初次DMEK且术前矫正远视力(CDVA)相当的眼作为对照。主要结局参数为CDVA。次要结局指标为中央角膜厚度(CCT)、内皮细胞密度和再气泡形成率(RR)。
初次和二次DMEK之间的平均时间间隔(±标准差)为12.5±6个月。重复DMEK组术前CDVA(logMAR)为1.97±0.90,初次DMEK组为1.38±0.92。在6个月时,两组视力均有显著改善(重复DMEK组,0.49±0.35,<0.01;初次DMEK组,0.40±0.36,<0.01)。在所有检查时间点(术后1、3和6个月),两组之间的CDVA无显著差异。术后3个月和6个月时两组的平均CCT值无显著差异(>0.05)。两组的RR均为23%(n = 3)。
重复DMEK是初次DMEK术后角膜失代偿情况下一种有效的治疗方法。重复DMEK的功能结果,尤其是视力,与仅接受单次DMEK的患者相当。